Gufic Biosciences Limited - Laporan Laba Rugi (TTM)

Gufic Biosciences Limited
IN ˙ BSE
₹ 364.80 ↓ -19.35 (-5.04%)
2025-04-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Gufic Biosciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 3,538 4,005 4,877 6,777 7,434 7,489 7,792 6,937 6,744 6,798 6,906 7,204 7,604 7,847 8,067 8,145 8,038 8,098 8,198 8,407
Change (%) 13.19 21.78 38.95 9.70 0.74 4.04 -10.97 -2.78 0.80 1.60 4.31 5.56 3.20 2.80 0.97 -1.31 0.75 1.24 2.55
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,847 2,188 2,565 3,690 4,179 4,121 4,207 3,505 3,310 3,295 3,393 3,586 3,823 3,913 3,986 3,878 3,835 3,824 3,747 3,807
Change (%) 18.47 17.22 43.87 13.24 -1.39 2.09 -16.70 -5.56 -0.46 2.98 5.69 6.61 2.35 1.87 -2.72 -1.09 -0.30 -2.01 1.61
% of Revenue 52.21 54.64 52.60 54.46 56.22 55.03 53.99 50.52 49.08 48.47 49.13 49.78 50.28 49.87 49.42 47.61 47.72 47.22 45.71 45.29
Gross Operating Profit 1,691 1,817 2,312 3,086 3,255 3,368 3,585 3,432 3,434 3,503 3,513 3,618 3,781 3,934 4,080 4,267 4,202 4,274 4,451 4,600
Change (%) 7.42 27.27 33.50 5.46 3.48 6.43 -4.25 0.05 2.01 0.29 2.97 4.51 4.05 3.72 4.56 -1.51 1.71 4.14 3.34
% of Revenue 47.79 45.36 47.40 45.54 43.78 44.97 46.01 49.48 50.92 51.53 50.87 50.22 49.72 50.13 50.58 52.39 52.28 52.78 54.29 54.71
SG&A 557 588 691 782 853 865 913 896 896 922 940 960 1,026 1,092 1,132 1,153 1,206 1,247 1,271 1,340
Change (%) 5.54 17.50 13.09 9.18 1.31 5.65 -1.90 0.01 2.84 2.02 2.07 6.94 6.45 3.64 1.84 4.58 3.39 1.91 5.47
% of Revenue 15.75 14.69 14.17 11.53 11.48 11.55 11.72 12.92 13.29 13.56 13.61 13.32 13.50 13.92 14.04 14.16 15.00 15.40 15.50 15.94
R&D
Change (%)
% of Revenue
OpEx 3,155 3,507 4,200 5,683 6,267 6,282 6,501 5,778 5,621 5,671 5,753 6,026 6,353 6,559 6,755 6,854 6,735 6,825 7,062 7,330
Change (%) 11.17 19.76 35.30 10.28 0.24 3.48 -11.12 -2.72 0.89 1.45 4.75 5.42 3.25 2.99 1.46 -1.74 1.34 3.47 3.80
% of Revenue 89.17 87.58 86.13 83.87 84.31 83.88 83.43 83.30 83.35 83.42 83.30 83.65 83.54 83.59 83.74 84.15 83.79 84.28 86.14 87.19
Operating Income 383 497 677 1,093 1,167 1,207 1,291 1,159 1,123 1,127 1,153 1,178 1,251 1,288 1,312 1,291 1,303 1,273 1,136 1,077
Change (%) 29.84 36.01 61.61 6.70 3.46 6.96 -10.25 -3.09 0.37 2.33 2.10 6.26 2.93 1.84 -1.58 0.93 -2.31 -10.73 -5.19
% of Revenue 10.83 12.42 13.87 16.13 15.69 16.12 16.57 16.70 16.65 16.58 16.70 16.35 16.46 16.41 16.26 15.85 16.21 15.72 13.86 12.81
Interest Expense -123 -126 -118 -115 -75 -48 -40 -32 -32 -44 -66 -98 -127 -137 -146 -159 -158 -176 -231 -277
Change (%) 1.81 -6.39 -2.55 -34.23 -36.42 -16.44 -20.47 1.81 34.75 51.80 47.69 29.13 8.05 6.51 9.25 -0.49 10.93 31.59 19.94
% of Revenue -3.49 -3.14 -2.41 -1.69 -1.01 -0.64 -0.51 -0.46 -0.48 -0.64 -0.96 -1.36 -1.66 -1.74 -1.81 -1.95 -1.97 -2.17 -2.82 -3.30
Net Income 243 305 442 769 829 884 958 857 826 819 797 793 823 842 861 864 849 820 696 619
Change (%) 25.32 45.08 73.79 7.81 6.72 8.36 -10.60 -3.65 -0.84 -2.64 -0.54 3.78 2.33 2.30 0.27 -1.67 -3.48 -15.04 -11.18
% of Revenue 6.88 7.61 9.07 11.34 11.15 11.81 12.30 12.35 12.24 12.04 11.54 11.01 10.82 10.73 10.68 10.60 10.57 10.12 8.50 7.36

Source: Capital IQ

Other Listings
IN:GUFICBIO ₹ 355.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista